Alector Inc. (NASDAQ:ALEC) is one of the best stocks under $3 to invest in. On October 21, Alector announced the topline ...

New results on the oral Alzheimer's pill, valiltramiprosate, claims it can slow down the brain atrophy that causes ...

A nationwide clinical trial is testing whether an existing drug could benefit patients with Alzheimer's disease, in hopes of making symptom-improving medication more accessible for people experiencing ...

The experimental pill ALZ-801 slowed memory decline by 50% and reduced brain shrinkage in early Alzheimer's patients with ...

Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

A team of investigators looked at possible dementia clinical trial requirements that could exclude people based on race and ethnicity. Overall, 82% of the trials they examined had criteria that ...

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...

A significant challenge in developing therapy and care for Alzheimer’s disease that work for people of different ethnic and racial backgrounds is recruitment and retention of traditionally ...

Credit: Getty Images Clinical trial investigators explore the headway made by diversity, equity, and inclusion initiatives in clinical trials of Alzheimer disease and related dementias and the ...

An annual review of clinical trials for Alzheimer’s disease highlights a growing number of active trials – and drugs – in the development pipeline and offers optimism for the global effort to find a ...

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly available cough syrup that's already being studied for its positive effect on ...